Arwen Podesta, MD, discusses key factors for the successful implementation of prescription digital therapeutics (PDTs) in clinical settings and how PDT manufacturers can support this process.
How Magellan’s Behavior Health Program Saved up to $4,300 PMPY
November 7th 2023Using an AI platform, Magellan Health was able to better support providers in prescribing behavioral health medications and addressing medication problems, which reduced pharmacy costs and increased adherence.
Read More